Insulin receptor sensitization restores neocortical excitation/inhibition balance in a mouse model of autism
Open Access
- 22 February 2018
- journal article
- research article
- Published by Springer Nature in Molecular Autism
- Vol. 9 (1) , 1-8
Abstract
Met receptor tyrosine kinase regulates neurogenesis, differentiation, migration, connectivity, and synaptic plasticity. The human Met gene has been identified as a prominent risk factor for autism spectrum disorder (ASD). Met gene-altered mice serve as useful models for mechanistic studies of ASD. Inactivation of Met in excitatory cortical neurons in mice (Emx1 cre /Met flox mice) yields a phenotype in which significantly decreased GABAA receptor-mediated inhibition shifts the excitation/inhibition (E/I) balance toward excitation in the somatosensory cortex. Further, unlike that seen in wild-type mice, insulin does not increase inhibition in the mutant cortex, suggesting that one of the consequences of kinase inactive Met gene could be desensitization of insulin receptors. To test this hypothesis, we investigated the effects of insulin receptor sensitizer, pioglitazone, on inhibition in the somatosensory thalamocortical circuitry. We used whole-cell patch clamp electrophysiology and analyzed excitatory and inhibitory responses of cortical layer IV excitatory cells following stimulation of their thalamic input in thalamocortical pathway intact brain slices. We applied insulin alone and insulin + a thiazolidinedione, pioglitazone (PIO), to test the effects of sensitizing insulin receptors on inhibitory responses mediated by GABAA receptors in the somatosensory cortex of Emx1 cre /Met flox mice. In WT brain slices, application of insulin together with PIO did not enhance the effect of insulin alone. In contrast, PIO application induced a much larger inhibition than that of insulin alone in Met-defective cortex. Thus, insulin resistance of GABAA receptor-mediated response in Met mutant mice may result from desensitized insulin receptors. Sporadic clinical studies reported improved behavioral symptoms in children with autism following PIO treatment. We show that PIO can aid in normalization of the E/I balance in the primary somatosensory cortex, a potential physiological mechanism underlying the positive effects of PIO treatment.Keywords
Funding Information
- National Institutes of Health (NS092216)
This publication has 44 references indexed in Scilit:
- Neurophysiology and Regulation of the Balance Between Excitation and Inhibition in Neocortical CircuitsBiological Psychiatry, 2017
- The Pleiotropic MET Receptor Network: Circuit Development and the Neural-Medical Interface of AutismBiological Psychiatry, 2017
- Control of Neuronal Development by T-Box Genes in the Brain2017
- Receptor Tyrosine Kinase MET Interactome and Neurodevelopmental Disorder Partners at the Developing SynapseBiological Psychiatry, 2016
- Reduced Glutamate Release in Adult BTBR Mouse Model of Autism Spectrum DisorderNeurochemical Research, 2016
- Insulin and insulin-like growth factor receptors in the brain: Physiological and pathological aspectsEuropean Neuropsychopharmacology, 2014
- Common circuit defect of excitatory-inhibitory balance in mouse models of autismJournal of Neurodevelopmental Disorders, 2009
- Dynamic gene and protein expression patterns of the autism‐associated met receptor tyrosine kinase in the developing mouse forebrainJournal of Comparative Neurology, 2009
- Exuberant thalamocortical axon arborization in cortex-specific NMDAR1 knockout miceJournal of Comparative Neurology, 2005
- Thalamocortical responses of mouse somatosensory (barrel) cortexin vitroNeuroscience, 1991